JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 2.42 HKD -5.1%
Market Cap: HK$1B

Intrinsic Value

The intrinsic value of one JW (Cayman) Therapeutics Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 2.42 HKD, JW (Cayman) Therapeutics Co Ltd is hidden .

JW (Cayman) Therapeutics Co Ltd Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
JW (Cayman) Therapeutics Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

JW (Cayman) Therapeutics Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if JW (Cayman) Therapeutics Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about JW (Cayman) Therapeutics Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JW (Cayman) Therapeutics Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for JW (Cayman) Therapeutics Co Ltd.

Explain Valuation
Compare JW (Cayman) Therapeutics Co Ltd to

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
solvency
Score
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
CN
Biotechnology
Market Cap
1B HKD
IPO
Nov 3, 2020
CN
Biotechnology
Market Cap
1B HKD
IPO
Nov 3, 2020
Price
HK$
¥
How do you feel about JW (Cayman) Therapeutics Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
JW (Cayman) Therapeutics Co Ltd

Efficiency

Free Cash Flow Analysis
JW (Cayman) Therapeutics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

Price Targets Summary
JW (Cayman) Therapeutics Co Ltd

Wall Street analysts forecast JW (Cayman) Therapeutics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JW (Cayman) Therapeutics Co Ltd is 6.16 HKD with a low forecast of 6.1 HKD and a high forecast of 6.34 HKD.

Lowest
Price Target
6.1 HKD
152% Upside
Average
Price Target
6.16 HKD
155% Upside
Highest
Price Target
6.34 HKD
162% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

JW (Cayman) Therapeutics Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for JW (Cayman) Therapeutics Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one JW (Cayman) Therapeutics Co Ltd stock?

The intrinsic value of one JW (Cayman) Therapeutics Co Ltd stock under the Base Case scenario is hidden HKD.

Is JW (Cayman) Therapeutics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2.42 HKD, JW (Cayman) Therapeutics Co Ltd is hidden .

Back to Top